05 November, 2018
in News
Our latest news
09 October, 2018
in News
Japanese decisions in Prismaccess and Evalumade
05 July, 2018
in News
Drug Reimbursement and Pricing Policy in Taiwan
30 May, 2018
in News
FDA wishes faster approval for gene therapies
14 May, 2018
in News
Prioritis at ISPOR Baltimore
13 March, 2018
in News
Prioritis at Pharma Pricing and Market Access congress London
26 February, 2018
in News
Spain, a new financing model for high economic-impact medicines
19 February, 2018
in News
Prismaccess’ data in an international study in oncology
14 February, 2018
in News
2018, innovations and new economic models
09 February, 2018
in News